Order results by:
Issue | Title | |
Vol 16, No 2 (2020) | Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation | Abstract similar documents |
Yu. P. Skirdenko, N. A. Nikolaev | ||
"... anticoagulants (DOACs) (χ2=1.44; p<0.49, Pearson) and significantly more in individuals taking warfarin ..." | ||
Vol 18, No 6 (2022) | Effect of ABCB1 Gene Carriage and Drug-Drug Interactions on Apixaban and Rivaroxaban Pharmacokinetics and Clinical Outcomes in Patients with Atrial Fibrillation and Deep Vein Thrombosis | Abstract similar documents |
L. V. Fedina, I. N. Sychev, T. D. Rastvorova, E. V. Strigunkova, A. A. Kachanova, Z. A. Sozaeva, P. O. Bochkov, A. V. Vardanyan, K. B. Mirzayev, D. A. Sychev | ||
"... apixaban together with a CYP3A4/P-gp inhibitor were 3.5 times more likely to have hemorrhagic complications ..." | ||
Vol 18, No 6 (2022) | Left Ventricular Thrombosis: Current Perspective and Use of Direct Oral Anticoagulants | Abstract similar documents |
A. D. Aga, A. A. Sokolova, D. A. Napalkov | ||
"... with this potentially fatal complication very briefly. LVT can complicate myocardial infarction where its incidence ..." | ||
Vol 18, No 4 (2022) | Prevention of Cardioembolic Complications in Patients with Atrial Fibrillation: Efficacy and Safety of Left Atrial Appendage Isolation and Oral Anticoagulants | Abstract similar documents |
D. V. Pevzner, N. S. Kostritca, A. K. Alieva, I. A. Merkulova, I. S. Yavelov, E. V. Merkulov, I. E. Chazova | ||
"... received DOACs or warfarin. The observation period was 3 years. Mortality, cardioembolic complications ..." | ||
Vol 17, No 5 (2021) | Gastrointestinal Bleeding: a Cardiologist's Point of View | Abstract similar documents |
O. V. Averkov, L. N. Mishchenko | ||
"... antagonists (warfarin) as well as direct oral anticoagulants (DOAC): dabigatran, rivaroxaban, apixaban ..." | ||
Vol 20, No 4 (2024) | Should a physician use the Beers criteria when prescribing direct oral anticoagulants to elderly patients? | Abstract similar documents |
N. M. Vorobyeva, I. P. Malaya, V. D. Zakiev, O. N. Tkacheva | ||
"... ) and venous thromboembolic complications (VTE) should be avoided in favor of safer alternative anticoagulants ..." | ||
Vol 19, No 5 (2023) | Inhospital outcomes of myocardial infarction in patients receiving direct oral anticoagulants | Abstract similar documents |
M. G. Chashchin, A. Yu. Gorshkov, O. M. Drapkina | ||
"... ) in patients receiving continuous direct oral anticoagulant (DOAC) therapy. Material and methods. Data from ..." | ||
Vol 14, No 2 (2018) | NEW DIRECT ORAL ANTICOAGULANTS FOR TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION IN REAL-WORLD SETTING | Abstract similar documents |
Zh. D. Kobalava, S. V. Villevalde, A. A. Shavarov | ||
"... and systemic thromboembolic (STE) complications as warfarin, although DOACs were associated with less risk ..." | ||
Vol 17, No 5 (2021) | Efficiency of the Left Atrial Appendage Thrombus Dissolution in Patients with Persistent Nonvalvular Atrial Fibrillation with Warfarin or Direct Oral Anticoagulants Therapy | Abstract PDF (Eng) similar documents |
E. S. Mazur, V. V. Mazur, N. D. Bazhenov, Yu. A. Orlov | ||
"... with persistent nonvalvular atrial fibrillation receiving warfarin and direct oral anticoagulants (DOAC ..." | ||
Vol 19, No 3 (2023) | Current insights into the possible role of laboratory monitoring of effectiveness and safety of direct oral anticoagulants | Abstract similar documents |
S. R. Gilyarevsky, N. K. Vereina, M. V. Golshmid | ||
"... the blood level of DOACs are considered in cases of the development of diseases or complications in which ..." | ||
Vol 17, No 4 (2021) | Antithrombotic Management for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention | Abstract similar documents |
A. V. Panov | ||
"... inhibitors and direct oral anticoagulant (DOAC) instead of vitamin K antagonists. The primary choice of DOAC ..." | ||
Vol 10, No 3 (2014) | PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN ATRIAL FIBRILLATION - RAT POISON OR NEW ORAL ANTICOAGULANTS: DO WE HAVE A CHOICE, AND SHOULD WE BE AFRAID TO MAKE IT? FIRST CLINICAL EXPERIENCE WITH RIVAROXABAN IN NIZHNY NOVGOROD | Abstract similar documents |
L. Y. Koroleva, I. V. Kolesnichenko, V. P. Nosov, I. I. Gritsenko, E. S. Timoschenko | ||
"... Adequate primary and secondary prevention of thromboembolic complications is one of the main goals ..." | ||
Vol 11, No 6 (2015) | PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN ATRIAL FIBRILLATION - RAT POISON OR NEW ORAL ANTICOAGULANTS: DO WE HAVE A CHOICE, AND SHOULD WE BE AFRAID TO MAKE IT? FIRST CLINICAL EXPERIENCE WITH RIVAROXABAN IN NIZHNY NOVGOROD | Abstract similar documents |
L. Y. Koroleva, I. V. Kolesnichenko, V. P. Nosov, I. I. Gritsenko, E. S. Timoschenko | ||
"... Adequate primary and secondary prevention of thromboembolic complications is one of the main goals ..." | ||
Vol 5, No 3 (2009) | SAFETY OF LONGTERM THERAPY WITH WARFARIN: POSSIBILITY OF TREATMENT RENEWING AFTER HEMORRHAGIC COMPLICATIONS | Abstract similar documents |
E. S. Kropacheva | ||
"... complications is analyzed according to the evidence base medicine approach. Possible hemorrhagic complications ..." | ||
Vol 16, No 3 (2020) | Clinical and Pathophysiological Aspects of the Effect of Anticoagulants on Bone Tissue | Abstract similar documents |
O. D. Ostroumova, I. V. Goloborodova | ||
"... to the progression of osteoporosis and its complications, which in turn can negatively affect the prognosis ..." | ||
Vol 17, No 2 (2021) | Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation in Real Clinical Practice: in Appropriate Dose Reductions | Abstract similar documents |
V. A. Ionin, O. I. Bliznuk, E. I. Baranova, E. V. Shlyakhto | ||
"... Aim. To study the frequency of administration of direct oral anticoagulant (DOACs) in doses ..." | ||
Vol 15, No 4 (2019) | Optimization of Pharmacotherapy with Direct Oral Anticoagulants: the Need to Choose the Right Dosage Regimen | Abstract similar documents |
A. I. Kochetkov, O. D. Ostroumova | ||
"... of direct oral anticoagulants (DOACs) compared with vitamin K antagonists due to the extensive body ..." | ||
Vol 12, No 5 (2016) | The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin | Abstract similar documents |
I. Yu. Koroleva, I. V. Kolesnichenko, V. P. Nosov, M. V. Zlobin, D. I. Abelevich | ||
"... stroke and systemic thromboembolic complications (TEC), bleeding in patients with non-valvular atrial ..." | ||
Vol 14, No 6 (2018) | Specific Antidotes for Direct Oral Anticoagulants in Life-Threatening Bleeding | Abstract PDF (Eng) similar documents |
A. B. Sumarokov, L. I. Buryachkovskaya, N. V. Lomakin | ||
"... anticoagulants (DOACs) inhibitors, as antidotes for DOAC when stopping life-threatening bleeding. DOAC therapy ..." | ||
Vol 16, No 2 (2020) | The Current Status of Direct Oral Anticoagulants in Cancer-Related Venous Thromboembolism Treatment | Abstract similar documents |
К. V. Lobastov, I. V. Schastlivtsev | ||
"... complications of DOACs. The results of published trials are reflected in the current guidelines ..." | ||
Vol 9, No 3 (2013) | ANTICOAGULANT THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: DRUG CHOICE AND DOSAGE ADJUSTMENT | Abstract similar documents |
E. L. Dolgova, I. M. Sokolov, Yu. G. Shvarts | ||
"... Data on the problem of thromboembolic complications in non-valvular atrial fibrillation ..." | ||
Vol 17, No 6 (2021) | Changes in Prescribing Antithrombotic Therapy in Patients with Atrial Fibrillation in the Multidisciplinary Hospital in Volgograd from 2012 to 2020 | Abstract similar documents |
A. S. Gerasimenko, O. V. Shatalova, V. S. Gorbatenko, V. I. Petrov | ||
"... ,5% (р<0,001), снизилась частота назначения варфарина с 71,9% до 18,3% (р<0,001), возросла частота ..." | ||
Vol 11, No 3 (2015) | ANALYSIS OF THE INFLUENCE OF THROMBOEMBOLIC COMPLICATIONS PREVENTION WITH ORAL ANTICOAGULANTS ON BUDGET IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION | Abstract similar documents |
A. V. Rudakova | ||
"... Atrial fibrillation (AF) is a risk factor for thromboembolic complications, requiring ..." | ||
Vol 18, No 3 (2022) | Clinically Significant Drug Interactions for Direct Oral Anticoagulants: State of the Art | Abstract similar documents |
S. R. Gilyarevsky | ||
"... the efficacy and safety of the use of direct oral anticoagulants (DOACs) in clinical practice. Data on drug ..." | ||
Vol 14, No 5 (2018) | Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable | Abstract similar documents |
D. A. Napalkov, A. A. Sokolova, M. A. Gabitova, L. N. Uddin | ||
"... В данной статье затрагиваются вопросы применения прямых оральных антикоагулянтов (ПОАК) у ..." | ||
Vol 17, No 4 (2021) | Changes in anticoagulant prescription in a general hospital in 2008-2018 | Abstract similar documents |
E. B. Kleymenova, V. A. Otdelenov, M. D. Nigmatkulova, S. A. Payushchik, A. A. Chernov, O. D. Konova, L. P. Yashina, A. M. Cherkashov, D. A. Sychev | ||
"... oral anticoagulants (DOAC) prescription in clinical guidelines for venous thromboembolism (VTE) and AF ..." | ||
Vol 6, No 4 (2010) | ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION: PROBLEMS AND PROSPECTS | Abstract similar documents |
A. Y. Rychkov, N. Y. Khor'kova, A. A. Bliznyakov | ||
"... of clinical studies on the possibility of effective reduction in frequency of thromboembolic complications ..." | ||
Vol 6, No 5 (2010) | THE INVASIVE DENTAL PROCEDURES IN PATIENTS TREATING WITH WARFARIN: POSSIBILITIES AND PROSPECTS FOR SAFETY | Abstract similar documents |
T. V. Kozlova, I. M. Makeyeva, V. Y. Doroshina, S. I. Bokareva | ||
"... is specified. Modifications of the patient dental health card are offered to prevent complications associated ..." | ||
Vol 14, No 4 (2018) | Physician’s Adherence to Clinical Guidelines for in-Hospital Anticoagulant Prescribing | Abstract similar documents |
A. A. Chernov, E. V. Kleymenova, D. A. Sychev, L. P. Yashina, M. D. Nigmatkulova, V. A. Otdelenov, S. A. Payushchik | ||
"... patients, including warfarin (39.5%), direct oral anticoagulants (DOAC) (46.5%) and low-molecular weight ..." | ||
Vol 12, No 5 (2016) | Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation | Abstract similar documents |
N. A. Novikova, A. N. Volovchenko | ||
"... stroke. The risk of thromboembolic complications increases significantly when performing for electrical ..." | ||
Vol 20, No 4 (2024) | Nephroprotective and anticoagulant therapy in patients with atrial fibrillation and chronic kidney disease: real-world data | Abstract similar documents |
A. I. Listratov, I. I. Ivanov, N. K. Ziskina, V. V. Efimenko, A. V. Zhavoronkova, E. S. Milyakova, A. A. Kudrjavtseva, D. A. Napalkov, A. A. Sokolova | ||
"... .1%), statins — 362 (78%), SGLT2i — 63 (13.6%), direct oral anticoagulants (DOACs) — 203 (43.8%) and warfarin ..." | ||
Vol 7, No 2 (2011) | PECULIAR PROPERTIES OF ANTITHROMBOTIC THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION. IS IT POSSIBLE TO DO THE TREATMENT SAFE? | Abstract similar documents |
I. V. Zotova, D. A. Zateyshchikov | ||
"... complications. Possible ways to minimize the hemorrhagic risk in different groups of hypertensive patients who ..." | ||
Vol 20, No 5 (2024) | Effectiveness and safety of direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease: a systematic review and meta-analysis of clinical trials | Abstract similar documents |
E. M. Mezhonov, Z. M. Safiullina, Y. A. Vyalkina, S. V. Shalaev | ||
"... oral anticoagulants" or "direct oral anticoagulants" or "novel oral anticoagulant" or "NOAC" or "DOAC ..." | ||
Vol 8, No 3 (2012) | RIVAROXABAN IN THE PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
M. Yu. Gilyarov | ||
"... препаратами (ацетилсалициловая кислота, варфарин) отдельно представлены альтернативные антитромботические ..." | ||
Vol 15, No 4 (2019) | Safety of Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Chronic Kidney Disease | Abstract similar documents |
V. I. Petrov, O. V. Shatalova, A. S. Gerasimenko, V. S. Gorbatenko | ||
"... oral anticoagulants for the prevention of thromboembolic complications in patients with atrial ..." | ||
Vol 18, No 5 (2022) | Thrombodynamics Test in Assessing the Risk of Thrombus Formation in Patients with Atrial Fibrillation Taking Direct Oral Anticoagulants | Abstract PDF (Eng) similar documents |
Z. A. Gebekova, I. I. Ivanov, A. Asambayeva, A. I. Skripka, A. A. Sokolova, D. A. Napalkov, T. A. Vuimo | ||
"... different direct oral anticoagulants (DOACs) using Thrombodynamics test. Materials and methods ..." | ||
Vol 17, No 2 (2021) | Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage | Abstract similar documents |
A. S. Gerasimenko, V. S. Gorbatenko, O. V. Shatalova, V. I. Petrov | ||
"... Intracerebral hemorrhage (ICH) is severe and fatal complication of anticoagulant therapy ..." | ||
Vol 15, No 5 (2019) | Clinical Case: Atypical Warfarin-induced Skin Necrosis | Abstract similar documents |
T. V. Kondratieva, L. V. Popova, S. S. Karachev, A. S. Lishuta, M. Z. Kanevskaya | ||
"... Warfarin-induced skin necrosis (WISN) is a rare complication of antivitamin K therapy, which occurs ..." | ||
Vol 3, No 2 (2007) | VARFARIN DOSE REGIME APPROACHS BASED ON PHARMACOGENETICS TEST RESULTS: REAL POSSIBILITY TO OPTIMIZE THE PHARMACOTHERAPY | Abstract similar documents |
D. A. Sychev, I. M. Antonov, S. V. Zagrebin, N. A. Gasanov, V. G. Kukes | ||
"... Indirect anticoagulants effectively prevent thromboembolic complications in patients with high ..." | ||
Vol 13, No 5 (2017) | WARFARIN AND ITS IMPORTANCE IN THE ERA OF NEW ORAL ANTICOAGULANTS. ISSUES OF MONITORING THE EFFECTIVENESS AND SAFETY OF TREATMENT | Abstract similar documents |
S. Yu. Martsevich, Y. V. Lukina | ||
"... to a decrease in the number of thromboembolic complications, and from the results of some RCTs – to a decrease ..." | ||
Vol 15, No 2 (2019) | Studies of Anticoagulant Therapy in Frail Elderly Patients: Problems of Terminology and Methodology | Abstract similar documents |
Sergey N. Bel'diev, Irina V. Medvedeva, Dmitry Yu. Platonov, Galina Yu. Trufanova | ||
"... сравнению с варфарином только терапия ривароксабаном снижала риск инсульта / системной эмболии и ..." | ||
Vol 10, No 2 (2014) | SECONDARY PREVENTION OF STROKE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: THE CLINICIANS’ VIEWPOINT | Abstract similar documents |
E. A. Drozdova | ||
"... терапии антагонистом витамина К варфарином и прямым ингибитором тромбина дабигатраном. ..." | ||
Vol 15, No 5 (2019) | Anticoagulant Therapy as a Tool for the Prevention of Cognitive Impairment Associated with Atrial Fibrillation | Abstract similar documents |
O. D. Ostroumova, A. I. Kochetkov, S. P. Korchagina, T. M. Ostroumova, M. S. Chernyaeva, A. A. Kirichenko | ||
"... to direct oral anticoagulants (DOACs). In randomized clinical trials, meta-analyses and systematic reviews ..." | ||
Vol 15, No 1 (2019) | Assessment of Antithrombotic Therapy in Patients with Atrial Fibrillation for 2015-2017 According to the Registry of the Clinic of the Scientific Research Institute of Medical Problems of the North of Krasnoyarsk City | Abstract similar documents |
A. A. Tuchkov, N. G. Gogolashvili, R. A. Yaskevich | ||
"... with the risk of thromboembolic complications, and also to study the dynamics of the frequency of administration ..." | ||
Vol 12, No 5 (2016) | Treatment Adherence as a New Choice Factor for Optimization of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation and Hemostatic Gene Polymorphisms | Abstract PDF (Eng) similar documents |
Yu. P. Skirdenko, A. V. Shustov, V. V. Zherebilov, N. A. Nikolayev | ||
"... be considered in patients with low adherence for prevention of thromboembolic complications. ..." | ||
Vol 14, No 1 (2018) | NEW APPROACHES TO INDIVIDUALIZED CHOICE OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
Ju. P. Skirdenko, N. A. Nikolayev | ||
"... was the low adherence to medical support, which directly related with the frequency of complications ..." | ||
Vol 10, No 2 (2014) | ANALYSIS OF ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT ATRIAL FIBRILLATION (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
V. I. Petrov, O. V. Shatalova, A. S. Maslakov | ||
"... complications (CHA2DS2-VASc≥2) was revealed in 93% patients (n=245), 65% (n=172) of them received warfarin ..." | ||
Vol 17, No 4 (2021) | Effect of Direct Oral Anticoagulants for Ulcer Epithelization and Laser Doppler Flowmetry Parameters In Patients with Diabetic Foot Syndrome and Atrial Fibrillation | Abstract similar documents |
V. I. Petrov, N. V. Rogova, T. N. Кuzmina, A. S. Lishuta | ||
"... therapy with the addition of direct oral anticoagulants (DOAC). Material and methods. An open-label ..." | ||
Vol 7, No 6 (2011) | DABIGATRAN ETEXILATE FOR PREVENTION OF CARDIOEMBOLIC COMPLICATIONS IN NONVALVULAR ATRIAL FIBRILLATION: HOW TO DO THE INTERVENTION MORE EFFECTIVE AND SAFER | Abstract similar documents |
I. S. Yavelov | ||
"... Application of dabigatran etexilate for prevention of cardioembolic complications in nonvalvular ..." | ||
Vol 14, No 1 (2018) | THE CONTROL OF INTERNATIONAL NORMALISED RATIO IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH WARFARIN IN OUTPATIENT AND HOSPITAL SETTINGS: DATA FROM RECVASA REGISTRIES | Abstract similar documents |
M. M. Loukianov, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. Val. Yakusevich, V. Vl. Yakusevich, T. A. Gomova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, M. A. Bichurina, L. A. Matskevich, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, A. D. Deev, O. M. Drapkina, s. A. Boytsov | ||
"... values, at which the risk of cardioembolic stroke and other thromboembolic complications is proven ..." | ||
Vol 12, No 4 (2016) | Clinical significance of new oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation: not all dreams come true | Abstract similar documents |
Yu. A. Bunin, S. V. Miklishanskaya | ||
"... варфарин. В связи с известными недостатками применения варфарина, для клинической практики очень важным ..." | ||
Vol 20, No 6 (2024) | Multivessel coronary artery stenting complicated by stent thrombosis in the setting of hereditary thrombophilia: a clinical case | Abstract similar documents |
Z. M. Safiullina, E. M. Mezhonov, S. V. Viatchinina, Yu. A. Vyalkina, A. Kh. Sereshcheva | ||
"... infarction and its thrombotic complications, including those associated with coronary artery stenting ..." | ||
Vol 8, No 4 (2012) | WARFARIN IN PATIENTS WITH CARDIOEMBOLIC STROKE | Abstract similar documents |
E. N. Dankovtseva, S. L. Arkhipov, D. A. Zateyshchikov | ||
"... Представлен анализ современной литературы по проблеме применения варфарина у больных ..." | ||
Vol 8, No 5 (2012) | RISK OF THROMBOEMBOLIC COMPLICATIONS AND ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT AND RECURRENT ATRIAL FIBRILLATION IN REAL CLINICAL PRACTICE | Abstract similar documents |
I. V. Grajfer, L. E. Kuvshinova, P. V. Dolotovskaya, O. V. Reshet'ko, N. V. Furman | ||
"... fibrillation (AF) with the risk level of thromboembolic complications (TEC), calculated with the СHADS2 and CHA ..." | ||
Vol 7, No 5 (2011) | ANALYSIS OF DIRECT COSTS ASSOCIATED WITH THE USE OF WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
Yu. B. Belousov, I. S. Yavelov, D. Yu. Belousov, E. V. Afanasieva | ||
"... Цель. Провести анализ структуры затрат , ассоциированных с подбором дозы варфарина и контролем ..." | ||
Vol 15, No 1 (2019) | Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation | Abstract similar documents |
V. I. Petrov, O. V. Shatalova, A. S. Gerasimenko, V. S. Gorbatenko | ||
"... complications was found in 1% (n=3) of patients in 2012 and 0.6% (n=3) in 2016. All these patients received ..." | ||
Vol 16, No 6 (2020) | The Oral Anticoagulants Administration in Elderly Patients with Geriatric Syndromes: What's New? | Abstract similar documents |
N. M. Vorobyeva, O. N. Tkacheva | ||
"... syndromes, as well as in elderly patients with venous thromboembolic complications and frailty syndrome ..." | ||
Vol 16, No 1 (2020) | Decrease in Efficacy of Warfarin as a Result of Drug-Drug Interaction (Case Report) | Abstract similar documents |
N. T. Vatutin, G. G. Taradin, G. A. Ignatenko, E. S. Gasendich, A. V. Harchenko, I. B. Povaljaeva | ||
"... межлекарственным взаимодействием. К числу наиболее популярных антикоагулянтов относят варфарин, который наряду со ..." | ||
Vol 16, No 2 (2020) | Specificities of Approaches to Anticoagulant Therapy in Comorbid Patients with Atrial Fibrillation, Diabetes Mellitus and Impaired Kidney Function | Abstract similar documents |
N. V. Drobotya, E. Sh. Guseynova, A. A. Pirozhenko | ||
"... comprehensively. Along with the prevention of thromboembolic complications, it is necessary that the selected ..." | ||
Vol 7, No 1 (2011) | ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS | Abstract similar documents |
M. Yu. Gilyarov, V. A. Sulimov | ||
"... предсердий. Рассмотрены факторы эффективности терапии варфарином, а также возможности применения новых ..." | ||
Vol 8, No 2 (2012) | QUALITY OF LIFE AND ITS DYNAMICS IN PATIENTS WITH ATRIAL FIBRILLATION AFTER LEAVING THE INTERNATIONAL CLINICAL TRIAL | Abstract similar documents |
E. L. Artanova, L. E. Kon'shina, I. M. Sokolov, Y. G. Shvarts | ||
"... варфарин, после выхода из международного клинического исследования. Материал и методы. В исследовании ..." | ||
Vol 15, No 4 (2019) | Elderly Patients with Atrial Fibrillation: Focus on Comorbidity and Safety of Anticoagulant Therapy | Abstract similar documents |
D. A. Napalkov, A. A. Sokolova | ||
"... благоприятный профиль эффективности и безопасности ривароксабана в сравнении с варфарином у пациентов 75 лет и ..." | ||
Vol 19, No 3 (2023) | Recurrent bleeding during standard anticoagulant therapy in comorbid patients with atrial fibrillation: a clinical case report | Abstract similar documents |
A. A. Kudriavtseva, E. V. Kolpachkova, Z. A. Gebekova, T. A. Sadulaeva, A. A. Sokolova, D. A. Napalkov | ||
"... The question of the safety of direct oral anticoagulants (DOACs), despite their high efficacy ..." | ||
Vol 13, No 6 (2017) | PREDICTORS OF THE RISK OF HEMORRHAGIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION RECEIVING LONGTERM THERAPY WITH DIRECT ORAL ANTICOAGULANTS | Abstract similar documents |
A. А. Sokolova, A. V. Zhilenko, I. L. Tsarev,, D. A. Napalkov, V. V. Fomin | ||
"... the development of bleeding during anticoagulant therapy with direct oral anticoagulants (DOAC). Material ..." | ||
Vol 21, No 1 (2025) | Practical aspects of perioperative management in patients with non-valvular atrial fibrillation receiving direct oral anticoagulants | Abstract similar documents |
E. N. Markova, T. Yu. Vedenikin, A. A. Kuzub, N. V. Kuchieva, A. R. Navasardyan, O. N. Dzhioeva | ||
"... fibrillation (AF) receiving direct oral anticoagulants (DOACs) and undergoing elective surgical interventions ..." | ||
Vol 7, No 4 (2011) | SPECIAL CONSIDERATIONS REGARDING WARFARIN DOSE TITRATION IN PATIENTS WITH ATRIAL FIBRILLATION DEPENDING ON CLINICAL FACTORS | Abstract similar documents |
E. L. Artanova, E. V. Saleeva, I. M. Sokolov, Y. G. Shvarts | ||
"... варфарина у больных фибрилляцией предсердий. Материал и методы. У 68 пациентов с сочетанием фибрилляции ..." | ||
Vol 9, No 4 (2013) | COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL PRACTICE | Abstract similar documents |
L. E. Kuvshinova, N. V. Furman, P. V. Dolotovskaya, Ya. P. Dovgalevsky | ||
"... ) к проведению плановой кардиоверсии (КВ) при лечении варфарином и дабигатраном Материал и методы ..." | ||
Vol 10, No 4 (2014) | NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY | Abstract similar documents |
D. A. Napalkov, A. A. Sokolova | ||
Vol 16, No 1 (2020) | Control Of Anticoagulation Therapy in Atrial Fibrillation (COAT-AF Study) in Real Clinical Practice | Abstract similar documents |
A. A. Zarudsky, A. A. Gavrilova, Т. S. Filinichenko | ||
"... каждого пациента просчитаны баллы по шкале CHA2DS2-VASc. Для пациентов, получавших варфарин, оценивали ..." | ||
Vol 16, No 3 (2020) | Thrombosis of Prosthetic Cardiac Valve: Difficulties of Diagnostics on the Example of a Clinical Case with Lethal Outcome | Abstract similar documents |
A. A. Novoselova, S. S. Yakushin | ||
"... установкой механического протеза в аортальную позицию и дальнейшего постоянного приема варфарина, с ..." | ||
Vol 14, No 5 (2018) | Excessive Hypocoagulation in Therapy with Warfarin within Polypharmacy: Using online database Multi-Drug Interaction Checker and Graphic “Time-Effect-Drug Administration” to Eliminate Adverse Drug Event (Case Report) | Abstract similar documents |
G. S. Krasnov, I. V. Kazancev | ||
"... -Drug Interaction Checker) выявлены взаимодействия, которые привели к НЛР: варфарин+розувастатин ..." | ||
Vol 17, No 2 (2021) | Analysis of Anticoagulant Therapy in the Elderly Patients, in Clinical Practice of Family Medicine Centers in the Kyrgyz Republic | Abstract similar documents |
S. M. Mamatov, B. Kanat kyzy, A. O. Musakeev, N. K. Kinderbaeva, T. J. Tagaev | ||
"... больным был назначен варфарин, адекватная антикоагуляция к концу года составила всего 11,8%. Ривароксабан ..." | ||
Vol 16, No 5 (2020) | Changes in Antithrombotic Therapy of Atrial Fibrillation in the Hospital in 2011-2012 and 2016-2017 (Pharmacoepidemiological Analysis) | Abstract similar documents |
O. V. Reshetko, A. V. Sokolov, N. V. Furman, V. V. Agapov | ||
"... to 2011-2012 mainly due to the increase in the spectrum of direct OACs (DOACs) (p<0.05). Conclusion ..." | ||
Vol 21, No 2 (2025) | Anticoagulant therapy in patients with cardioembolic subtype of ischemic stroke and atrial fibrillation | Abstract similar documents |
E. A. Naryshkina, M. I. Chashkina, E. S. Zadykyan, N. K. Kurbanalieva, E. M. Zakaryan, M. V. Serova, D. A. Andreev, A. G. Komarova, K. E. Eroshkin, A. A. Kulesh, D. A. Sychev | ||
"... .9% of patients, the prescribed doses of direct oral anticoagulant (DOAC) did not correspond to clinical ..." | ||
Vol 18, No 1 (2022) | Modern Anticoagulant Therapy for Atrial Fibrillation: Patient Adherence in Clinical Practice | Abstract similar documents |
Yu. P. Skirdenko, N. A. Nikolaev, K. G. Pereverzeva, A. Yu. Timakova, A. S. Galus, S. S. Yakushin | ||
"... at high risk of thromboembolic complications in Ryazan and Omsk. To study adherence, a questionnaire ..." | ||
Vol 9, No 1 (2013) | EFFECT OF DIFFERENT GLUCOSE BLOOD LEVELS ON THE DEVELOPMENT OF CARDIOVASCULAR DISEASES AND COMPLICATIONS | Abstract similar documents |
E. V. Akhmedova, Z. A. Toguzova, M. N. Mamedov | ||
"... causes of death in patients with DM are macrovascular complications. Intensive hypoglycemic therapy ..." | ||
Vol 12, No 2 (2016) | ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOW TO COMBINE ANTIPLATELET AND ANTICOAGULANT THERAPY, DEPENDING ON THE CLINICAL SITUATION? | Abstract similar documents |
D. A. Napalkov, A. A. Sokolova, A. V. Rodionov | ||
"... исследования ARISTOTLE, в котором сравниваются эффективность и безопасность апиксабана в сравнении с варфарином ..." | ||
Vol 11, No 1 (2015) | PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
A. V. Rudakova | ||
"... предсердий (ФП) относятся антитромботическая терапия антагонистами витамина К (варфарин), антитромбоцитарными ..." | ||
Vol 9, No 5 (2013) | APPLICATIONS OF PHARMACOGENETIC TESTING FOR PERSONALIZATION OF THERAPY WITH ORAL ANTICOAGULANTS IN RUSSIA | Abstract similar documents |
D. A. Sychev, R. E. Kazakov, V. A. Otdelenov, A. B. Prokofiev | ||
"... варфарина и выбора новых оральных антикоагулянтов на основе результатов фармакогенетического тестирования, а ..." | ||
Vol 10, No 3 (2014) | COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION | Abstract similar documents |
A. V. Rudakova, V. A. Parfenov | ||
"... предсердий (ФП) относятся антитромботическая терапия антагонистами витамина К (варфарин), антитромбоцитарными ..." | ||
Vol 8, No 1 (2012) | PHARMACOECONOMIC EVALUATION OF DABIGATRAN VS WARFARIN IN CARDIOVASCULAR EVENTS PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION | Abstract similar documents |
Yu. B. Belousov, V. Yu. Mareev, I. S. Yavelov, D. Yu. Belousov | ||
"... фармакоэкономическую эффективность применения дабигатрана этексилата в сравнении с варфарином в профилактике сердечно ..." | ||
Vol 2, No 3 (2006) | ANTITHROMBOTIC THERAPY OF ISCHEMIC HEART DISEASE: FROM FAST ACTING ANTIAGGREGANTS TO STATINES AND NITRATE OXIDE. IS IT REAL? | Abstract similar documents |
I. A. Latfullin, A. A. Podolskaya | ||
"... ацетилсалициловая кислота, варфарин, тиклопидин и клопидогрель. Приводятся данные по изучению новых ..." | ||
Vol 7, No 4 (2011) | LEFT VENTRICULAR CLOT LYSIS DUE TO COMBINED ANTICOAGULANT THERAPY WITH WARFARIN AND FRAXIPARINE IN PATIENT WITH DILATED CARDIOMYOPATHY AND CHRONIC HEART FAILURE. THE CLINICAL CASE | Abstract similar documents |
O. V. Uskova, K. O. Sobolev, G. E. Gendlin, A. V. Melekhov | ||
"... результате комбинированной антикоагулянтной терапии фраксипарином и варфарином у больной дилатационной ..." | ||
Vol 5, No 4 (2009) | PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS | Abstract similar documents |
S. Y. Martsevich, N. P. Kutishenko | ||
Vol 9, No 4 (2013) | STATINS IN PREVENTION OF ISCHEMIC STROKE | Abstract similar documents |
A. V. Susekov, A. B. Blohin, Z. G. Luginova, E. J. Soloveva, N. V. Maltseva, O. E. Tarasova, V. V. Kuharchuk | ||
Vol 9, No 4 (2013) | NORVASC® IN RUSSIA 20 YEARS LATER: CONTINUATION OF THE HISTORY | Abstract similar documents |
A. V. Rudenko, B. A. Rudenko | ||
Vol 10, No 4 (2014) | MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION | Abstract similar documents |
E. A. Belikov, K. V. Davtyan, O. N. Tkacheva | ||
"... Prevention of thromboembolic complications in patients with atrial fibrillation during catheter ..." | ||
Vol 10, No 5 (2014) | STATINS USE IN THE PERIOPERATIVE PERIOD ACCORDING TO THE EVIDENCE-BASED MEDICINE | Abstract similar documents |
V. V. Samoylenko, O. P. Shevchenko, V. I. Burtsev | ||
"... modification of cardiovascular complications in the perioperative period. Particular attention has recently ..." | ||
Vol 19, No 5 (2023) | Patients with atrial fibrillation in outpatient practice: clinical characteristics and outcomes over a 10-year observation period (data from the REQUAZA AF registrу — Yaroslavl) | Abstract similar documents |
V. V. Yakusevich, V. Vl. Yakusevich, S. Yu. Martsevich, M. M. Lukyanov, O. M. Drapkina | ||
"... AF complications were stroke and transient ischemic attack, with a total of 74 episodes ..." | ||
Vol 11, No 5 (2015) | Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism | Abstract similar documents |
A. V. Rudakova | ||
"... to the weighted average auctions prices for NOACs. The costs of monitoring and treatment of complications were ..." | ||
Vol 11, No 2 (2015) | ANTICOAGULANT THERAPY IN EVERYDAY CLINICAL PRACTICE: DATA OF THE RETROSPECTIVE CROSS-SECTIONAL STUDY | Abstract PDF (Eng) similar documents |
V. A. Sulimov, D. A. Napalkov, A. A. Sokolova, A. V. Jilenko, O. S. Anikina | ||
"... %) was revealed in 79%. 8.45% of the vitamin K antagonist treated patients developed hemorrhagic complications. 16 ..." | ||
Vol 12, No 5 (2016) | Features of Modern Anticoagulant Therapy in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease | Abstract similar documents |
I. S. Daabul, A. A. Sokolova, D. A. Napalkov | ||
"... результатам основных исследований не уступали или превосходили варфарин в отношении баланса эффективности и ..." | ||
Vol 15, No 4 (2019) | The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries) | Abstract similar documents |
M. M. Loukianov, S. Yu. Martsevich, O. M. Drapkina, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. Val. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. Y. Andreenko, V. G. Klyashtorny, E. V. Kudryashov, E. Yu. Okshina, M. A. Panagopulu, S. A. Boytsov | ||
"... % мужчин), в т.ч. варфарин – 817 пациентам (26%) и новые оральные антикоагулянты (НОАК) – 518 (16 ..." | ||
Vol 7, No 6 (2011) | CORONARY EMBOLISM WITH FRAGMENTED THROMBUS FROM THE LEFT VENTRICLE IN PATIENT WITH POSTINFARCTION ANEURYSM | Abstract similar documents |
Yu. F. Salakhova, S. V. Gar'kina, T. V. Kislukhin, D. V. Duplyakov, V. S. Ivanov, E. R. Perunova, E. I. Bazhenova, S. E. Burnazyan, S. M. Khokhlunov | ||
"... The thrombus formation in the left ventricle (LV) cavity is a frequent complication of myocardial ..." | ||
Vol 11, No 2 (2015) | THE EFFECTIVENESS OF LERCANIDIPINE IN REDUCING THE RISK OF ARTERIAL HYPERTENSION COMPLICATIONS | Abstract similar documents |
E. EL. Trisvetova | ||
"... Despite progress in reducing the risk of hypertension (HT) complications, control of blood ..." | ||
Vol 1, No 3 (2005) | TRANSIENT ISCHEMIC ATTACK AS AN ARTERIAL HYPERTENSION COMPLICATION | Abstract similar documents |
G. N. Gorochovskaya, A. P. Kondrachin, A. I. Martinov | ||
Vol 17, No 1 (2021) | Bicuspid Aortic Valve: Morphology, Clinic, Diagnosis, Complications | Abstract similar documents |
Y. L. Trysvetava | ||
Vol 18, No 5 (2022) | Assessment and Correction of the Cardiac Complications Risk in Non-cardiac Operations – What's New? | Abstract similar documents |
A. N. Sumin | ||
"... Cardiovascular complications after non-cardiac surgery are the leading cause of 30-day mortality ..." | ||
Vol 6, No 5 (2010) | EFFECT OF BETA-BLOCKERS ON BLOOD PRESSURE, PERIOPERATIVE COMPLICATIONS AND HOSPITAL STAY DURATION IN PATIENTS WITH INTERMEDIATE RISK OF CARDIOVASCULAR COMPLICATIONS AFTER ROUTINE CHOLECYSTECTOMY: AN OPEN COMPARATIVE RANDOMIZED STUDY | Abstract similar documents |
O. L. Barbarash, R. V. Repnikova, T. V. Shoforus, O. I. Golofaeva | ||
"... year worldwide, and cardiovascular complications happen in 500 000 - 900 000 patients. Aim ..." | ||
Vol 9, No 4 (2013) | USE OF BETA-BLOCKERS IN THE PERIOPERATIVE PERIOD: HOW STRONG ARE THE EVIDENCES? | Abstract similar documents |
V. V. Samoylenko, O. P. Shevchenko, V. I. Burtsev | ||
"... of risk modification of cardiovascular complications in the perioperative period. Therefore, special ..." | ||
1 - 100 of 389 Items | 1 2 3 4 > >> |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)